BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Kidney
,
Early pregnancy factor
,
Fluoxetine
,
rs2230926
,
VEGFA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
masitinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
DHRS2
ANO1
SERPINA3
MAL
MUC4
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
heterocyclic compound binding
cytosol
organic cyclic compound metabolic process
cellular aromatic compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment ser…
Safety of masitinib in patients with neurodegenerative diseases: a meta-analysis of randomized contr…
Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, p…
Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity.
Masitinib Inhibits Hepatitis A Virus Replication.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Masitinib Plus Gemcitabine in Pancreatic Cancer
Masitinib in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
Masitinib in Patients With Mild to Moderate Alzheimer's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ